4D Molecular Therapeutics
-$0.78 (-2.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell FDMT and other stocks, options, and ETFs commission-free!
About FDMT
4D Molecular Therapeutics, Inc. engages in the design, development, and commercialization of transformative gene therapeutic products for serious unmet medical conditions. It offers products for optalmology, cardiology, and pulmonology.
CEO
David H. Kirn
Employees
—
Headquarters
Emeryville, California
Founded
2013
FDMT Key Statistics
Market Cap
934.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
106.58K
High Today
$34.15
Low Today
$32.25
Open Price
$33.31
Volume
202.64K
52 Week High
$55.11
52 Week Low
$30.55
FDMT Earnings
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours